US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

39.31

+0.94502.46%

Post-market: 38.72-0.5850-1.49%16:10 EDT

Volume:553

Turnover:21.44K

Market Cap:2.95M

PE:- -

High:39.31

Open:38.72

Low:38.72

Close:38.36

52wk High:45.88

52wk Low:25.71

Shares:75.00K

Float Shares:75.00K

Volume Ratio:0.03

T/O Rate:0.74%

Dividend:0.62

Dividend Rate:1.58%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors

Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China

Biofrontera announces FDA approval of Ameluz supplemental new drug application

FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses

Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions

THOMSON REUTERS

Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4

THOMSON REUTERS

FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®

THOMSON REUTERS

Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses

THOMSON REUTERS

Scholar Rock Wins FDA Approval for SMA Therapy

Scholar Rock price target raised to $84 from $76 at BMO Capital

Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors

Vertex Minerals Revises Timeline for Proposed Securities Issue

Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara

Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street

Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts

Scholar Rock announces FDA approval of isembyld

Amgen Inc. Stock Underperforms Friday When Compared to Competitors

Moderna Inc. Stock Rallies 5.4%, Outperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/TBXU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":39.3051,"timestamp":1789416000000,"preClose":38.3601,"halted":0,"volume":553,"hourTrading":{"tag":"盘后","latestPrice":38.7201,"preClose":39.3051,"latestTime":"16:10 EDT","volume":6,"amount":235.7004,"timestamp":1789416604133,"change":-0.585,"changeRate":-0.014884,"amplitude":0},"delay":0,"changeRate":0.024634972275880414,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"Not Yet Opened","change":0.945,"latestTime":"09-14 16:00:00 EDT","open":38.72,"high":39.3051,"low":38.72,"amount":21444,"amplitude":0.015253,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789459200000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":38.3601,"sharesOutstanding":100001,"nav":38.336,"aum":2875239.83,"dividendRate":0.01582,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.7201,"preClose":39.3051,"latestTime":"16:10 EDT","volume":6,"amount":235.7004,"timestamp":1789416604133,"change":-0.585,"changeRate":-0.014884,"amplitude":0},"volumeRatio":0.034418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.034418,"shares":75001,"dividePrice":0.6218,"high":39.3051,"amplitude":0.015253,"preClose":38.3601,"low":38.72,"week52Low":25.71,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":39.3051,"eps":0,"divideRate":0.01582,"volume":553,"delay":0,"ttmEps":0,"open":38.72,"prevYearClose":31.065,"prevWeekClose":38.3601,"prevMonthClose":42.9245,"prevQuarterClose":32.1223,"fiveDayClose":44.3833,"twentyDayClose":37.6716,"sixtyDayClose":29.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667695453","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695453","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695453?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:36","pubTimestamp":1789418160,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 1.87% to $146.41 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Gilead Sciences Inc. closed 6.92% below its 52-week high of $157.29, which the company achieved on February 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and Abbott Laboratories  rose 1.12% to $103.09.Trading volume  remained 1.5 million below its 50-day average volume of 6.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","LU1934455277.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","GILD","IE00B7SZLL34.SGD","LU2357627491.SGD","MEDI","LU1839511570.USD","IBB","LU0965509101.SGD","BK4583","LU0823416689.USD","LU1066053197.SGD","BK4568","LU0882574055.USD","LU1571399168.USD","LU2468319806.SGD","SG9999015986.USD","IE00B19Z3581.USD","BK4139","LU0058720904.USD","IE00BKVL7J92.USD","LU1061106388.HKD","LU1430594728.SGD","TMED","BK4550","BIB","LU2112291526.USD","BMED","IE00BSNM7G36.USD","LU1934455194.USD","LU0234570918.USD","IE0002270589.USD","BK4532","LU1674673691.USD","LU1057294990.SGD","LU2089984988.USD","BK4588","LU1066051498.USD","BK4566","IE00B3T34201.USD","BBH","LU0965509010.AUD","LU1585245621.USD","SG9999015945.SGD","SG9999015978.USD","LU1037948541.HKD","LU2087621335.USD","BK4585","LU0289739699.SGD","BK4578","LU0109394709.USD","LU1674673428.USD","TBXU","LU0861579265.USD","LU1778281490.HKD","LU1934455863.HKD","SG9999015952.SGD","IBBQ","LU2324357040.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU0889565916.HKD","LU0320765992.SGD","LU0965508806.USD","LU0965509283.SGD","LU0859254822.USD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667695950","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2667695950","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667695950?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:35","pubTimestamp":1789418100,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  advanced 1.10% to $381.50 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.48% to 7,619.98 and Dow Jones Industrial Average  falling 0.29% to 52,421.20.The stock's rise snapped a five-day losing streak.Amgen Inc. closed 14.66% below its 52-week high of $447.03, which the company achieved on August 25th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  rose 0.28% to $266.32, Pfizer Inc.  remained unchanged, and AbbVie Inc.  rose 1.81% to $261.77.Trading volume  eclipsed its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 14, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU0320765992.SGD","IBBQ","IE0002141913.USD","LU0058720904.USD","BK4566","LU2242646821.SGD","LU2242652126.USD","LU1571399168.USD","LU0889565916.HKD","BBH","BK4599","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","PBE","BK4581","LU1061106388.HKD","LU1983299246.USD","LU2112291526.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","PJP","LU0109394709.USD","LU1023059063.AUD","BK4534","LU1057294990.SGD","BK4585","BK4139","SG9999001440.SGD","IE00B2B36J28.USD","BK4533","IE00BJT1NW94.SGD","AMGN","LU2089984988.USD","04332","TBXU","LU0868494617.USD","IE00B4R5TH58.HKD","BIB","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667667070","title":"Amgen’s Phase 3 Dazodalibep Study Nears Data Spotlight for Sjögren’s Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667667070","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667667070?lang=en_us&edition=fundamental","pubTime":"2026-09-15 00:30","pubTimestamp":1789403411,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. The phase 3 study A Phase 3 Randomized, Double-blind, Placebo-controlled Stu...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgens-phase-3-dazodalibep-study-nears-data-spotlight-for-sjogrens-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU0320765992.SGD","IBBQ","IE0002141913.USD","LU0058720904.USD","BK4566","LU2242646821.SGD","LU2242652126.USD","LU1571399168.USD","LU0889565916.HKD","BBH","BK4599","LU2468319806.SGD","IE00BJJMRZ35.SGD","LU0122379950.USD","PBE","BK4581","LU1061106388.HKD","LU1983299246.USD","LU2112291526.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","PJP","LU0109394709.USD","BK4211","BK4534","LU1023059063.AUD","BK4585","BK4139","LU1057294990.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4533","IE00BJT1NW94.SGD","AMGN","LU2089984988.USD","TBXU","LU0868494617.USD","IE00B4R5TH58.HKD","BIB","ISBC","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661729","title":"Roche, GSK's Lung-Cancer Drug Candidates Show Promise in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661729","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661729?lang=en_us&edition=fundamental","pubTime":"2026-09-14 22:04","pubTimestamp":1789394640,"startTime":"0","endTime":"0","summary":"1404 GMT - Roche Holding and GSK's Chinese partners reported strong clinical-trial data for their respective lung-cancer drug candidates in China-only clinical trials, analysts at J.P. Morgan write in a research note. Both drugs, one from GSK and partner Hansoh Pharmaceutical and another from Roche and MediLink, showed a 54% improvement in overall survival rates in the trials. This seems competitive relative to a 40% benefit shown by Amgen's Imdelltra in a global trial, the analysts say. Roche and MediLink's candidate tam-peli has a better tolerability profile than GSK and Hansoh's ris-rez, they add. Ris-rez has better median overall-survival data, but it will be important to confirm this result in a global trial, according to JPM. GSK shares rise 4.6% and Roche's jump 5.7%, while Hansoh's close 5.1% higher.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","AMGN","LU2112291526.USD","LU0109394709.USD","HRTS","LU1829250122.USD","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4532","LU1983299246.USD","IE0002141913.USD","BK4533","LU0889565916.HKD","03692","BK4007","BK4534","LU0122379950.USD","BK4566","LU1571399168.USD","LU2242652126.USD","LU0868494617.USD","GSKH","PBE","LU0320765992.SGD","BK4599","BK1589","RHHBY","BBH","LU2468319806.SGD","LU1023059063.AUD","GSK.UK","TBXU","GSK","LU1057294990.SGD","LU1061106388.HKD","CANC","BK4585","IBB","03165","BK4581","PJP","LU2089984988.USD","BK1191","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBBQ","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667661630","title":"Biofrontera announces FDA approval of Ameluz supplemental new drug application","url":"https://stock-news.laohu8.com/highlight/detail?id=2667661630","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667661630?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:35","pubTimestamp":1789392922,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) announced that the FDA has approved the company’s supplemental new drug application, or sNDA, for Ameluz topical gel, 10%, in co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biofrontera-announces-fda-approval-of-ameluz-supplemental-new-drug-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNX","IEIH","IYH","SYNB","TBXU","IDNA","FRTY","MEDI","PINK","GNMX","LABU","PSCH","RSPH","BK4007","LFSC","BK4588","IBB","BK4585","TECB","XLVX","MRNY","BFRI","GDOC","BMED","NVIB","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667669562","title":"FDA Approves Shorter Monitoring Time for Amgen’s Imdelltra First Two Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667669562","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667669562?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:06","pubTimestamp":1789391173,"startTime":"0","endTime":"0","summary":"FDA approves shorter monitoring time for Amgen’s Imdelltra first two dosesFDA cleared a label update for Amgen’s IMDELLTRA that cuts post-infusion monitoring for the first two doses to 6-8 hours.Prior","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDLtJX3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","IE00B4R5TH58.HKD","PBE","LU0289739699.SGD","IBBQ","IE00BJJMRZ35.SGD","LU1023059063.AUD","IE00BFTCPJ56.SGD","TBXU","BK4139","IE0009355771.USD","LU2112291526.USD","LU0868494617.USD","BK4533","IE00BJT1NW94.SGD","BK4581","LU0889565916.HKD","BK4534","LU0109394709.USD","LU2089984988.USD","LU0122379950.USD","LU1057294990.SGD","IBB","BK4566","LU1571399168.USD","BIB","LU1983299246.USD","LU2468319806.SGD","BK4599","BK4588","LU0058720904.USD","LU0320765992.SGD","BK4585","LU1061106388.HKD","BBH","IE0002141913.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU2242652126.USD","AMGN","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667778666","title":"Amgen - Imdelltra Monitoring Reduced to 6-8 Hours for First Two Infusions","url":"https://stock-news.laohu8.com/highlight/detail?id=2667778666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667778666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU2112291526.USD","LU0289739699.SGD","LU2089984988.USD","PBE","PJP","AMGN","BK4534","LU1061106388.HKD","BK4599","BIB","BK4533","LU0109394709.USD","LU0320765992.SGD","LU1057294990.SGD","LU1571399168.USD","BBH","TBXU","LU1023059063.AUD","LU0868494617.USD","LU0889565916.HKD","BK4588","IBB","LU2468319806.SGD","LU0122379950.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4139","IE00B2B36J28.USD","IE0009355771.USD","SG9999001440.SGD","BK4585","BK4566","BK4581","LU2242652126.USD","LU2242646821.SGD","IE0002141913.USD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667774666","title":"Amgen - Imdelltra Monitoring Remains 6-8 Hours for Third Dose, 3-4 Hours for Cycles 3-4","url":"https://stock-news.laohu8.com/highlight/detail?id=2667774666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667774666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2089984988.USD","BK4566","LU2242646821.SGD","BK4581","LU0289739699.SGD","BK4585","IE00BJT1NW94.SGD","BK4533","PJP","AMGN","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU2468319806.SGD","BK4588","IE00BFTCPJ56.SGD","LU0122379950.USD","LU0868494617.USD","LU0320765992.SGD","LU2112291526.USD","IBB","IE00B2B36J28.USD","LU0889565916.HKD","BK4599","IBBQ","PBE","TBXU","LU1571399168.USD","SG9999001440.SGD","BK4534","LU0109394709.USD","BK4139","LU0058720904.USD","BIB","LU1983299246.USD","LU1057294990.SGD","LU1061106388.HKD","LU2242652126.USD","IE0009355771.USD","BBH","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667701666","title":"FDA Approves Reduced Monitoring Time for First Two Doses of Imdelltra®","url":"https://stock-news.laohu8.com/highlight/detail?id=2667701666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667701666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","LU0320765992.SGD","LU2242646821.SGD","IE0002141913.USD","LU1061106388.HKD","LU1057294990.SGD","BK4139","PJP","LU0868494617.USD","BBH","LU0889565916.HKD","SG9999001440.SGD","LU2089984988.USD","BK4585","IBB","LU0109394709.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1571399168.USD","LU1023059063.AUD","LU2112291526.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BIB","BK4581","IE00BJJMRZ35.SGD","BK4534","BK4566","LU0289739699.SGD","IBBQ","BK4533","BK4599","LU0058720904.USD","LU0122379950.USD","AMGN","LU2242652126.USD","TBXU","PBE","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667082666","title":"Amgen - Patients to Receive Follow-up Assessment After First Two Imdelltra Doses","url":"https://stock-news.laohu8.com/highlight/detail?id=2667082666","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667082666?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:00","pubTimestamp":1789390805,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nTUA41PDLW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4599","LU1983299246.USD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","SG9999001440.SGD","BK4534","IE0002141913.USD","LU2089984988.USD","LU0889565916.HKD","LU2242652126.USD","LU0289739699.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","TBXU","BK4585","PJP","LU2242646821.SGD","BBH","PBE","BK4139","IBBQ","LU2112291526.USD","BK4566","BIB","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0109394709.USD","LU0868494617.USD","AMGN","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","BK4581","BK4533","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667066661","title":"Scholar Rock Wins FDA Approval for SMA Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2667066661","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667066661?lang=en_us&edition=fundamental","pubTime":"2026-09-14 20:32","pubTimestamp":1789389127,"startTime":"0","endTime":"0","summary":"The latest update is out from Scholar Rock Holding ( ($SRRK) ). On September 11, 2026, Scholar Rock announced U.S. FDA approval of ISEMBYLD (apiteg...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/scholar-rock-wins-fda-approval-for-sma-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","IYH","MRNY","TECB","PSCH","IDNA","MEDI","PINK","BMED","SYNB","FRTY","XLVX","LABU","NVIB","BK4585","BBP","GNMX","IEIH","MRNX","LFSC","GDOC","TBXU","RSPH","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667134663","title":"Scholar Rock price target raised to $84 from $76 at BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2667134663","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667134663?lang=en_us&edition=fundamental","pubTime":"2026-09-14 19:36","pubTimestamp":1789385772,"startTime":"0","endTime":"0","summary":"BMO Capital raised the firm’s price target on Scholar Rock (SRRK) to $84 from $76 and keeps an Outperform rating on the shares. The FDA approval of...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-price-target-raised-to-84-from-76-at-bmo-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDI","SYNB","BK4139","MRNY","SRRK","IEIH","FRTY","BK4588","BK4585","MRNX","IBRN","LFSC","IBB","GDOC","BBP","BMED","PSCH","GNMX","TECB","XLVX","THNR","NVIB","RSPH","IDNA","IYH","LABU","PINK","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667659991","title":"Sino Biopharmaceutical Stock Advances 4.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2667659991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667659991?lang=en_us&edition=fundamental","pubTime":"2026-09-14 16:30","pubTimestamp":1789374600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. advanced 4.3% to 5.48 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24917.60.The stock's rise snapped a three-day losing streak.Sino Biopharmaceutical Ltd. closed 38% below its 52-week high of HK$8.86, which the company achieved Sept. 15.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 1.8% and Amgen Inc. remained unchanged.Trading volume totaled 72.9 million shares, compared to the 50-day average of 98.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","AMGN","IE00BZ08YT58.USD","LU2112291526.USD","LU0109394709.USD","BK4588","IE0009355771.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU1983299246.USD","IE0002141913.USD","BK4533","LU0889565916.HKD","BK1521","BK4534","LU0122379950.USD","LU2242646821.SGD","01177","BK4566","LU1571399168.USD","LU2242652126.USD","LU0868494617.USD","BK1515","IE00BZ08YS42.EUR","PBE","LU0320765992.SGD","BK4599","BK1589","BK4139","IE00BFTCPJ56.SGD","HK0000165453.HKD","BBH","LU2468319806.SGD","LU1023059063.AUD","IE00BZ08YR35.GBP","TBXU","LU1057294990.SGD","LU1061106388.HKD","BK4585","IBB","PJP","BK4581","LU2089984988.USD","BK1191","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBBQ","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635488","title":"Vertex Minerals Revises Timeline for Proposed Securities Issue","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635488","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635488?lang=en_us&edition=fundamental","pubTime":"2026-09-14 07:40","pubTimestamp":1789342824,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has provided an update. Vertex Minerals Ltd. has updated its proposed securities placement timetable, revising t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-revises-timeline-for-proposed-securities-issue?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0058720904.USD","LU0109394709.USD","SG9999001176.USD","MTX","LU0234570918.USD","VERX","LU1559883803.SGD","LU1674673691.USD","BBH","LU0566484027.USD","PBE","LU2462157665.USD","LU1585245621.USD","LU1815336091.USD","TBXU","SG9999001176.SGD","LU0061475181.USD","IE00BJJMRZ35.SGD","BK4585","IBBQ","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","LU0417517546.SGD","LU2089984988.USD","BK4532","SGXZ57979304.SGD","LU0757428866.USD","LU1674673428.USD","LU0320765992.SGD","LU0079474960.USD","IE0009355771.USD","LU0432979614.USD","LU1430594728.SGD","LU2468319806.SGD","IDNA","BIB","IE00BJT1NW94.SGD","BK4109","LU2362541273.HKD","IE00B19Z9P08.USD","IBB","VRTX","BK4533","LU0256863811.USD","GNMX","BK4588","IE00B2B36J28.USD","LU1093756325.SGD","IE00B894F039.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667635862","title":"Telix Wins FDA Nod for First FET-PET Glioma Imaging Drug Pixclara","url":"https://stock-news.laohu8.com/highlight/detail?id=2667635862","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667635862?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:54","pubTimestamp":1789340092,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA approval for Pixclara, the first FET-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-nod-for-first-fet-pet-glioma-imaging-drug-pixclara?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","XLVX","MRNY","PSCH","IYH","BMED","FRTY","BK4588","IDNA","IEIH","SYNB","GDOC","RSPH","TECB","LFSC","GNMX","BK4585","BK4139","NVIB","LABU","PINK","TLX","MEDI","FET","TBXU","BBP","MRNX","BK4179"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666509524","title":"Heart Disease, a Historic Strength for Big Pharma, Becomes a Weakness - Heard on the Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2666509524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666509524?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:30","pubTimestamp":1789205400,"startTime":"0","endTime":"0","summary":"There is a strange paradox haunting healthcare investing right now.Heart disease remains humanity's top killer, yet for drugmakers and Wall Street, it is becoming one of the hardest places to make mon","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BWXC8680.SGD","GB00BDT5M118.USD","LU2417539215.USD","LU0385154629.USD","LU0208291251.USD","LU0320765489.SGD","IE00BKVL7J92.USD","LU2456880835.USD","IE00BK4W5M84.HKD","LU2242652126.USD","IHE","IE00BKPKM429.USD","LU1974910355.USD","IE00B775H168.HKD","LU2168564222.USD","TBXU","LU1267930730.SGD","LU0786609619.USD","GDOC","SGXZ57979304.SGD","LU1917777945.USD","SG9999015978.USD","AGNG","LU0133085943.USD","LU0889565916.HKD","LU0174119429.USD","LU0964807845.USD","SGXZ99366536.SGD","IXJ","LU1280957306.USD","SG9999017495.SGD","LU0114720955.EUR","LU1868836914.USD","LU1551013425.SGD","LU0787776722.HKD","LU0122379950.USD","LU0689472784.USD","LU2750360641.GBP","LU1366192091.USD","LU1629891620.HKD","LU0820561909.HKD","LU1720051108.HKD","LU2361044949.HKD","LU2746668974.SGD","IE00B1BXHZ80.USD","ELIS","LU0432979614.USD","IE00B4R5TH58.HKD","LU1868837136.USD","LU2023250504.SGD","LU2491050071.SGD","MHIP","LU2271345857.HKD","BBH","SG9999018865.SGD","LU0640476718.USD","BK4588","BK4533","LU0820561818.USD","LU1623119135.USD","NVOH","LU0106261372.USD","TRUH","SG9999001176.SGD","OZEM","SG9999014914.USD","FTXH","IE00BFSS8Q28.SGD","SG9999018857.SGD","LU0058720904.USD","LU0320765059.SGD","LU1989771016.USD","LU0097036916.USD","LU1868836591.USD","LU1868837300.USD","LU2168564149.EUR","SG9999013999.USD","LU0471298777.SGD","LU2361044865.SGD","LU0466842654.USD","LU2264538146.SGD","LU0868494617.USD","LU2168564495.EUR","LU2168563687.JPY","BK4516","LU0289739699.SGD","LU0109394709.USD","LU2213496289.HKD","IE00BK4W5L77.USD","LU2237438978.USD","LU0061475181.USD","NVS","SG9999014880.SGD","IE0002141913.USD","LU1232071149.USD","LU2023250330.USD","HRTS","LU2237443622.USD","LU2471134879.HKD","LU2491049909.HKD","LU2236285917.USD","LU0096364046.USD","LU0109391861.USD","LU0345770308.USD","LU2462157665.USD","LU2063271972.USD","LU2023251221.USD","LU0006306889.USD","LU0198837287.USD","CANC","LU2237443978.SGD","SG9999014898.SGD","BK4581","LU1571399168.USD","SG9999001176.USD","IE00BJT1NW94.SGD","LU0234572021.USD","LU0210536198.USD","IE0004445239.USD","LU0079474960.USD","LU0456855351.SGD","LU1093756168.USD","04332","AMGN","LU2471134796.USD","LU2750360997.AUD","LU2237443549.SGD","LU2552382215.SGD","IE0005OL40V9.USD","IE00B1XK9C88.USD","IE00BJJMRY28.SGD","LU1035775433.USD","BK4532","IE00BJLML261.HKD","LU1023059063.AUD","LU2461242641.AUD","LU0471298694.HKD","LU2237443895.HKD","LLY","PJP","LU2211815571.USD","LU1548497426.USD","LU0323591593.USD","LU0158827948.USD","LU0211331839.USD","IE00BJJMRZ35.SGD","LU2756315664.SGD","LU0094547139.USD","LU0417517546.SGD","LU0823434583.USD","LU2896262040.SGD","XLV","LU2089284900.SGD","LU0823434740.USD","IE0009355771.USD","LU0320765992.SGD","LU1064131342.USD","THNR","FHLC","SGXZ81514606.USD","LU1983299246.USD","LU2242646821.SGD","LU0203202063.USD","IE0001KFT4U8.USD","LU0353189680.USD","LLYX","SG9999014906.USD","IE00BJJMRX11.SGD","LU2111349929.HKD","JDOC","IE00BZ1G4Q59.USD","LU2265009873.SGD","PPH","SGXZ31699556.SGD","BK4534","LU2112291526.USD","LU1127390331.HKD","NVOC","LU0353189763.USD","LU2089984988.USD","BIB","LU1988902786.USD","LU1814569148.SGD","ELIL","WDNA","LU1323610961.USD","LU0154236417.USD","LU0238689110.USD","LU1868836757.USD","IE00B7KXQ091.USD","TMED","NVOX","LU0266013472.USD","LU2106854487.HKD","LU0158827781.USD","LU2471134952.CNY","ILDR","BK4599","IBB","LU0354030438.USD","LU0203201768.USD","LU1712237335.SGD","LU2756315318.SGD","LU2087625088.SGD","MEDI","PBE","SG9999015952.SGD","IYH","LU0316494557.USD","LU0256863811.USD","LU1061106388.HKD","LU1145028129.USD","LU2324357040.USD","LU1720051017.SGD","LU1093756325.SGD","LU2471134523.USD","LU2357305700.SGD","CURE","BK4007","LU0820562030.AUD","IE00B4JS1V06.HKD","LU2237443465.HKD","LU0882574055.USD","LU2462591350.SGD","LU2491050154.USD","LU1804176565.USD","LU0683600562.USD","IE00BFSS7M15.SGD","LU0672654240.SGD","RXL","IE00BN29S564.USD","LU2361045086.USD","IE00BKDWB100.SGD","LU0225283273.USD","SG9999015986.USD","LU0708995401.HKD","BK4139","SG9999001440.SGD","BK4585","LLYZ","LU0345770993.USD","LU0070302665.USD","LU0354030511.USD","LU1057294990.SGD","LU1291159041.SGD","LU1551013342.USD","BK4566","LU1691799644.USD","LU2168564065.EUR","LU2468319806.SGD","LU2552382132.HKD","LU0882574139.USD","LU2108987350.USD","LU0943347566.SGD","IE00B2B36J28.USD","BK4578","LU2360106947.USD","LU2746668461.USD","LU2237443382.USD","LU0823416689.USD","LU1069344957.HKD","IBBQ","LU2552382058.USD","VHT","LU2089283258.USD","LU1979441026.SGD","LU2602419157.SGD","LLII","NVO","SGXZ51526630.SGD","IE0004445015.USD","MEDX","IE00BFTCPJ56.SGD","SG9999015945.SGD","LU0256863902.USD","LU2028103732.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666506002","title":"Palo Alto, Eaton, Amgen, SpaceX, LMT Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2666506002","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666506002?lang=en_us&edition=fundamental","pubTime":"2026-09-12 17:01","pubTimestamp":1789203667,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($PANW) ), ( ($ETN) ), ( ($AMGN) ), ( ($SPCX) ) and ( ($LMT) ). Here is a breakdown of their recent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/palo-alto-eaton-amgen-spacex-lmt-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SPCQ","LU1861559042.SGD","UFO","TBXU","SPAL","LU0889565916.HKD","SPAX","SPCF","XOVL","XOVR","LOFD","FOWF","SHLD","SNK","BK4516","IDEF","LU1861220033.SGD","BIB","SPCG","WARP","PPA","LMTL","ORBX","ELOL","MISL","WSPC","IBBQ","BBH","LMTS","IBB","SPCM","SPCU","DIPR","LU1861558580.USD","NATO","SSPC","MARS","LU1162221912.USD","PJP","SPCX","WDGF","LMT","DSPC","DXYZ","PBE","AMGN","YSPC","LOFF","SPCH","LU1244550577.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666577803","title":"Scholar Rock announces FDA approval of isembyld","url":"https://stock-news.laohu8.com/highlight/detail?id=2666577803","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666577803?lang=en_us&edition=fundamental","pubTime":"2026-09-12 06:30","pubTimestamp":1789165818,"startTime":"0","endTime":"0","summary":"Scholar Rock (SRRK) announced that the FDA has approved isembyld for the treatment of spinal muscular atrophy in adults and children two years of a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/scholar-rock-announces-fda-approval-of-isembyld-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","THNR","RSPH","IBB","MRNX","PSCH","IBRN","NVIB","SRRK","IYH","BK4588","SYNB","PINK","LABU","BMED","TECB","BK4585","FRTY","LFSC","MRNY","TBXU","XLVX","MEDI","GDOC","GNMX","IEIH","IDNA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574557","title":"Amgen Inc. Stock Underperforms Friday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574557","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574557?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:35","pubTimestamp":1789158900,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Underperforms Friday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  shed 1.34% to $377.35 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.86% to 7,656.98 and the Dow Jones Industrial Average  rising 0.98% to 52,573.29.This was the stock's fifth consecutive day of losses.Amgen Inc. closed 15.59% below its 52-week high of $447.03, which the company achieved on August 25th.The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson  fell 0.29% to $265.58, Pfizer Inc.  rose 0.25% to $27.72, and AbbVie Inc.  rose 0.83% to $257.12.Trading volume  remained 337,805 below its 50-day average volume of 2.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 11, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIB","LU0058720904.USD","IE0009355771.USD","BK4533","IE00BFTCPJ56.SGD","LU1057294990.SGD","LU2242652126.USD","SG9999001440.SGD","BK4599","LU0109394709.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2089984988.USD","LU1061106388.HKD","04332","AMGN","BK4139","LU2242646821.SGD","BK4585","LU2112291526.USD","TBXU","IE00B2B36J28.USD","LU0122379950.USD","BK4566","IE00B4R5TH58.HKD","LU1571399168.USD","LU2468319806.SGD","PBE","LU0320765992.SGD","IBBQ","BK4588","LU0289739699.SGD","LU0868494617.USD","PJP","LU1023059063.AUD","BK4581","LU1983299246.USD","IBB","BK4534","IE00BJT1NW94.SGD","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666574302","title":"Moderna Inc. Stock Rallies 5.4%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2666574302","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666574302?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:33","pubTimestamp":1789158780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. advanced 5.4% to $143.97 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 26,333.04 and the Dow Jones Industrial Average rising 1.0% to 52,573.29.This was the stock's second consecutive day of gains.Moderna Inc. closed 18.5% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson fell 0.3% to $265.58, Pfizer Inc. rose 0.3% to $27.72, and Gilead Sciences Inc. fell 0.75% to $143.72.Trading volume totaled 15.3 million, compared to the 50-day average of 17.4 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357627491.SGD","IBBQ","LU0889565916.HKD","SG9999015978.USD","LU0965509283.SGD","MRNA","GNOM","TBXU","GILD","LU0965509101.SGD","LU1066051498.USD","LU1674673691.USD","BMED","LU0861579265.USD","LU1934455277.USD","LU0965509010.AUD","LU1778281490.HKD","BK4548","MRNY","BK4568","LU1430594728.SGD","BK4139","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0114720955.EUR","LU0965508806.USD","BK4534","LU1585245621.USD","IE00B19Z3581.USD","LGHT","BBH","IDNA","IBB","LU0058720904.USD","LU1674673428.USD","SG9999015952.SGD","LU0109394709.USD","MEDI","BK4578","LU2468319806.SGD","IE00B3T34201.USD","TMED","SG9999015986.USD","LU1571399168.USD","LU1057294990.SGD","MRNX","BK4588","LU0289739699.SGD","WDNA","BIB"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}